Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

1,2,3-Triazole-Benzofused Molecular Conjugates as Potential Antiviral Agents against SARS-CoV-2 Virus Variants
Jehan Y. Al‐Humaidi, Marwa M. Shaaban, Nadjet Rezki, et al.
Life (2022) Vol. 12, Iss. 9, pp. 1341-1341
Open Access | Times Cited: 36

Showing 1-25 of 36 citing articles:

An Overview of 1,2,3-triazole-Containing Hybrids and Their Potential Anticholinesterase Activities
Shah Alam Khan, Mohammad Jawaid Akhtar, Urvashee Gogoi, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 2, pp. 179-179
Open Access | Times Cited: 44
Biological importance and synthesis of 1,2,3-triazole derivatives: a review
Mira J. Vaishnani, Sabera Bijani, Mohamed Rahamathulla, et al.
Green Chemistry Letters and Reviews (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 30
Phenylpyrazolone-1,2,3-triazole Hybrids as Potent Antiviral Agents with Promising SARS-CoV-2 Main Protease Inhibition Potential
Arafa Musa, Hamada S. Abulkhair, Ateyatallah Aljuhani, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 3, pp. 463-463
Open Access | Times Cited: 33
Benzimidazole-Triazole Hybrids as Antimicrobial and Antiviral Agents: A Systematic Review
Maria Marinescu
Antibiotics (2023) Vol. 12, Iss. 7, pp. 1220-1220
Open Access | Times Cited: 28
Isatin based 1,2,3-Triazole Derivatives as Antimicrobial Agents: Synthesis, In silico docking and Molecular Dynamics Simulations
Vijay Kumar, Madhur Babu Singh, Prashant Singh, et al.
Journal of Molecular Structure (2024) Vol. 1312, pp. 138378-138378
Closed Access | Times Cited: 7
Development of 1,2,3-triazole hybrids as multi-faced anticancer agents co-targeting EGFR/mTOR pathway and tubulin depolymerization
Mennatallah A. Shaheen, Khaled M. Darwish, Safaa M. Kishk, et al.
Bioorganic Chemistry (2025) Vol. 156, pp. 108153-108153
Closed Access
Multifunctional Plumeria rubra nanoparticles: Antimicrobial, antiviral, antiparasitic and anti-inflammatory activities
Bassma H. Elwakil, Mohab H. Elsabrouty, Areej A. Eskandrani, et al.
Heliyon (2025) Vol. 11, Iss. 2, pp. e42044-e42044
Open Access
Microwave-assisted synthesis and in vitro and in silico studies of pyrano[3,2-c]quinoline-3-carboxylates as dual acting anti-cancer and anti-microbial agents and potential topoisomerase II and DNA-gyrase inhibitors
Ashraf A. Aly, Hisham A. Abd El-Naby, Essam Kh. Ahmed, et al.
RSC Advances (2025) Vol. 15, Iss. 3, pp. 1941-1956
Open Access
Synthesis of a new sulfadimidine Schiff base and their nano complexes as potential anti-COVID-19 and anti-cancer activity
Shimaa Hosny, Mona S. Ragab, Randa F. Abd El-Baki
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 18
1,2,3-triazole derivatives as antiviral agents
Naima Agouram
Medicinal Chemistry Research (2023) Vol. 32, Iss. 12, pp. 2458-2472
Closed Access | Times Cited: 14
Design and synthesis of chromene-1,2,3-triazole benzene sulfonamide hybrids as potent carbonic anhydrase-IX inhibitors against prostate cancer
Fawzia Faleh Albelwi, Mohamed S. Nafie, Nader R. Albujuq, et al.
RSC Medicinal Chemistry (2024) Vol. 15, Iss. 7, pp. 2440-2461
Closed Access | Times Cited: 4
A Novel Ambroxol-Derived Tetrahydroquinazoline with a Potency against SARS-CoV-2 Proteins
Alena I. Krysantieva, Julia К. Voronina, Damir A. Safin
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 5, pp. 4660-4660
Open Access | Times Cited: 12
Structural elucidation and in-silico evaluation of 1,2,4-triazole derivative as potent Omicron variant of SARS-CoV-2 spike protein inhibitor with pharmacokinetics ADMET and drug-likeness predictions
Dheeraj Kumar, B.S. Chethan, Veeresha Gowda Shalini, et al.
Journal of Molecular Structure (2023) Vol. 1297, pp. 136976-136976
Closed Access | Times Cited: 11
Design, Synthesis, and Anticancer and Antibacterial Activities of Quinoline-5-Sulfonamides
Andrzej Zięba, Dominika Pindjaková, Małgorzata Latocha, et al.
Molecules (2024) Vol. 29, Iss. 17, pp. 4044-4044
Open Access | Times Cited: 2
Fungal Secondary Metabolites/Dicationic Pyridinium Iodide Combinations in Combat against Multi-Drug Resistant Microorganisms
Ayoub M. Abdelalatif, Bassma H. Elwakil, Mohamed Zakaria, et al.
Molecules (2023) Vol. 28, Iss. 6, pp. 2434-2434
Open Access | Times Cited: 5
Click Synthesis, Antimicrobial, DNA Photocleavage and Computational Studies of Oxindole-Tethered 1 H -1,2,3-triazoles
Vijay Kumar, Kashmiri Lal, Ravinder Kumar, et al.
Future Medicinal Chemistry (2023) Vol. 15, Iss. 13, pp. 1115-1131
Closed Access | Times Cited: 5
Discovery of potential RSK1 inhibitors for cancer therapy using virtual screening, molecular docking, molecular dynamics simulation, and MM/GBSA calculations
Sevil Kalın, Ferah Cömert Önder
Journal of Biomolecular Structure and Dynamics (2023), pp. 1-21
Open Access | Times Cited: 5
1,2,3-Triazole Hybrids Containing Isatins and Phenolic Moieties: Regioselective Synthesis and Molecular Docking Studies
Loredana Maiuolo, Matteo Antonio Tallarida, Angelo Meduri, et al.
Molecules (2024) Vol. 29, Iss. 7, pp. 1556-1556
Open Access | Times Cited: 1
Synthesis, Characterization, Antimicrobial and In Silico Studies of isatin Schiff base linked 1,2,3‐triazole hybrids
Vijay Kumar, Akanksha Bhukal, Anirudh Pratap Singh Raman, et al.
Chemistry & Biodiversity (2024) Vol. 21, Iss. 7
Closed Access | Times Cited: 1
Novel bis-benzimidazole-triazole hybrids: anticancer study, in silico approaches, and mechanistic investigation
Moataz A. Soliman, Hany E. A. Ahmed, Elsayed H. Eltamany, et al.
Future Medicinal Chemistry (2024), pp. 1-15
Closed Access | Times Cited: 1
Nanoformulation-Based 1,2,3-Triazole Sulfonamides for Anti-Toxoplasma In Vitro Study
Fadwa M. Arafa, Heba Said, Doaa Hassan Osman, et al.
Tropical Medicine and Infectious Disease (2023) Vol. 8, Iss. 8, pp. 401-401
Open Access | Times Cited: 4
Trisubstituted 1,3,5-Triazines as Histamine H4 Receptor Antagonists with Promising Activity In Vivo
Agnieszka Olejarz‐Maciej, Szczepan Mogilski, Tadeusz Karcz, et al.
Molecules (2023) Vol. 28, Iss. 10, pp. 4199-4199
Open Access | Times Cited: 3
Benzimidazole-Triazole Hybrids as Antimicrobial and Antiviral Agents
Maria Marinescu
(2023)
Open Access | Times Cited: 3
Design, synthesis, and biological evaluation of indole-2-carboxamides as SARS CoV-2 main protease inhibitors
Hesham A. M. Gomaa, Mohamed E. Shaker, Sami I. Alzarea, et al.
Tetrahedron (2023) Vol. 146, pp. 133628-133628
Closed Access | Times Cited: 2
Design, Synthesis, and Biological Activity Evaluation of Novel AZT and Adenosine-Derived 1,2,3-Triazoles
Duc Anh Le, Ngoc Hung Truong, Van Dung Vu, et al.
Journal of Chemistry (2023) Vol. 2023, pp. 1-17
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top